133 Startups
  • Sector
  • Participated in
  • Year of participation

Protinhi

  • 2012
  • Other
  • Therapeutics
  • Venture Challenge
Combating viral infectious diseases with a high unmet medical need. Treating disease via protease inhibition.

Quirem Medical

  • 2012
  • 2016
  • Other
  • Therapeutics
  • Value Centre
Quirem Medical is an emerging medical device company with a mission to develop and commercialize the next generation microspheres for targeted interventional treatment of liver malignancies.

QurieGen

  • 2021
  • Enabling Technology
  • Venture Challenge
QurieGen provides quantitative information on the mode of action of drug molecules across multiple pathways over different timescales.

QVQ

  • 2011
  • Enabling Technology
  • Other
Labelled single domain antibodies from camelids (professionally called functionalized VHH) for Research and Imaging. 

River Biomedics

  • 2018
  • Enabling Technology
  • Venture Challenge
River BioMedics offers new human cardiac 3D models for target validation during drug discovery. Our 3D models are scalable to high-throughput and provide clinically relevant cardiac readouts for reliable drug efficacy validation.

Saturn

  • 2023
  • Medical Device
  • Venture Challenge
Saturn offers a personalized solution for Pelvic Organ Prolapse by providing a pessary with a perfect fit and optimal support for each patient's complex, unique anatomy.

Scope Biosciences

  • 2020
  • Diagnostics
  • Venture Challenge
CRISPR-Cas has revolutionized the field of gene editing and will also disrupt the field of molecular diagnostics. CRISPR diagnostics (CRISPR-Dx), combined with a pre-amplification step, are faster and easier than (q)PCR whilst obtaining results of the same quality.

Self-Screen

  • 2010
  • Diagnostics
  • Other
Development and clinical application of molecular assays for the early detection of cancer

Sella Therapies

  • 2021
  • Medical Device
  • Therapeutics
  • Venture Challenge
Sella Therapies is a clinical-stage medical device company developing a novel therapy for chronic pain relief that targets the body’s internal neuropeptide system.

Sencilia

  • 2023
  • Medical Device
  • Venture Challenge
Sencilia has developed a first-of-its-kind flow sensing device to reduce medication errors due to flow instabilities in intravenous infusions in neonates.